- HOME
- 홈페이지 이용안내
논문 기본정보
Distribution and Drug Resistance Status of Extended-Spectrum β-Lactamases Producing Klebsiella pneumoniae
논문 개요
| 기관명 | NDSL |
|---|---|
| 저널명 | 中華醫院感染學雜志 = Chinese journal of nosocomiology |
| ISSN | 1005-4529, |
| ISBN |
논문저자 및 소속기관 정보
| 저자(한글) | ZHAO, Dejun,FU, Weichan,ZHANG, Bixia,REN, Yujiang,CAO, Yan,MAO, Yue,YANG, Wei |
|---|---|
| 저자(영문) | |
| 소속기관 | |
| 소속기관(영문) | |
| 출판인 | |
| 간행물 번호 | |
| 발행연도 | 2008-01-01 |
| 초록 | OBJECTIVE To investigate the distribution and drug resistance status of extended-spectrum β-1actamases producing (ESBLs) Klebsiella pneumoniae and to provide the basis for clinic anti-infective treatment. METHODS To use ATB-expression analyzer to identify the microbe. The drug susceptibility was tested with the K-B method and the ESBLs producing strains detected by diffusion confirmed test. RESULTS Among 137 strains of identified K. pneumoniae, 34.3% of them(47 strains)produced ESBLs, and most had been shown in geriatrics ward. The drug resistance rate of ESBLs producing K. pneumoniae was higher than that in non-producing ESBLs one. So imipenem should be considered to be a preferred antibiotic when used on K. pneurnoniae seriously infected cases. CONCLUSIONS The drug resistance of K. pneurnoniae is a serious problem, we should pay attention on the status of ESBLs distribution, based on the susceptibility to choose the reasonable antibacterial to avoid the producing ESBLs bacteria spread out. |
| 원문URL | http://click.ndsl.kr/servlet/OpenAPIDetailView?keyValue=03553784&target=NART&cn=NART51531115 |
| 첨부파일 |
추가정보
| 과학기술표준분류 | |
|---|---|
| ICT 기술분류 | |
| DDC 분류 | |
| 주제어 (키워드) | Klebsiella pneumoniae,Extended-spectrum β-1actamases,Drug resistance status |